开云app官网登录入口网页版-官方正版

#皮下注射#

50篇内容 | 2202人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211094, encodeId=d5ee2211094af, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a> <a href='/topic/show?id=f46311051235' target=_blank style='color:#2F92EE;'>#埃万妥单抗#</a> <a href='/topic/show?id=c64a10641526' target=_blank style='color:#2F92EE;'>#拉泽替尼#</a>, objectTitle=四代药埃万妥单抗可皮下注射，给药时间缩短60倍且不良反应小！, objectType=article, longId=831173, objectId=25508311e337, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240621/1718954270423_5579292.jpg, objectUrl=/article/show_article.do?id=25508311e337, replyNumber=0, likeNumber=79, createdTime=2024-06-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=25508311e337, moduleTitle=四代药埃万妥单抗可皮下注射，给药时间缩短60倍且不良反应小！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=25508311e337)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1372267, encodeId=280b13e226760, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=JAMA子刊：皮下注射门冬胰岛素治疗儿童轻度糖尿病酮症酸中毒的成本-效果评估, objectType=article, longId=738480, objectId=469fe38480b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=469fe38480b6, replyNumber=0, likeNumber=61, createdTime=2022-09-09, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=469fe38480b6, moduleTitle=JAMA子刊：皮下注射门冬胰岛素治疗儿童轻度糖尿病酮症酸中毒的成本-效果评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=469fe38480b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372266, encodeId=cf5013e2266a7, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Dermatol Ther：与口服甲氨蝶呤相比，皮下注射甲氨蝶呤治疗银屑病的效果似乎更加, objectType=article, longId=737616, objectId=8f63e3761668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f63e3761668, replyNumber=0, likeNumber=72, createdTime=2022-09-03, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f63e3761668, moduleTitle=Dermatol Ther：与口服甲氨蝶呤相比，皮下注射甲氨蝶呤治疗银屑病的效果似乎更加, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f63e3761668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372265, encodeId=621313e226516, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症, objectType=article, longId=734049, objectId=0064e34049af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0064e34049af, replyNumber=0, likeNumber=69, createdTime=2022-08-02, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0064e34049af, moduleTitle=Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0064e34049af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372264, encodeId=fd0a13e2264e2, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！, objectType=article, longId=301023, objectId=9b6430102313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6430102313, replyNumber=0, likeNumber=72, createdTime=2022-03-19, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6430102313, moduleTitle=EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b6430102313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372263, encodeId=2b1f13e2263b0, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=JAAD：甲氨蝶呤从口服改为皮下注射的不良反应研究, objectType=article, longId=294016, objectId=ab9f29401631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab9f29401631, replyNumber=0, likeNumber=104, createdTime=2022-01-16, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab9f29401631, moduleTitle=JAAD：甲氨蝶呤从口服改为皮下注射的不良反应研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ab9f29401631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372262, encodeId=549513e226239, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Nat Med：2型糖尿病患者皮下注射艾塞那肽与心血管结局, objectType=article, longId=221685, objectId=647c22168537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=647c22168537, replyNumber=0, likeNumber=93, createdTime=2021-12-09, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=647c22168537, moduleTitle=Nat Med：2型糖尿病患者皮下注射艾塞那肽与心血管结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=647c22168537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372261, encodeId=f7bd13e22616e, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=J Urol：性腺机能减退患者中，肌内注射丙酸睾酮与皮下注射庚酸睾酮哪个效果好？, objectType=article, longId=220116, objectId=69ab220116f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69ab220116f3, replyNumber=0, likeNumber=70, createdTime=2021-11-12, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69ab220116f3, moduleTitle=J Urol：性腺机能减退患者中，肌内注射丙酸睾酮与皮下注射庚酸睾酮哪个效果好？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=69ab220116f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372260, encodeId=8d0a13e226026, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=皮下注射抽到回血，药水被染红，推还是不推呢？, objectType=article, longId=217500, objectId=4d6821e5001b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d6821e5001b, replyNumber=0, likeNumber=58, createdTime=2021-09-24, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d6821e5001b, moduleTitle=皮下注射抽到回血，药水被染红，推还是不推呢？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d6821e5001b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372259, encodeId=b84413e225902, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Mov Disord ：皮下注射左旋多巴新药，治疗帕金森，效果如何, objectType=article, longId=217418, objectId=a12d21e4186e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a12d21e4186e, replyNumber=0, likeNumber=86, createdTime=2021-09-23, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a12d21e4186e, moduleTitle=Mov Disord ：皮下注射左旋多巴新药，治疗帕金森，效果如何, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a12d21e4186e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372258, encodeId=3ade13e22580c, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！, objectType=article, longId=215762, objectId=968f215e627f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968f215e627f, replyNumber=0, likeNumber=66, createdTime=2021-08-17, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968f215e627f, moduleTitle=J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=968f215e627f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372257, encodeId=3e5213e22576f, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=NEJM：皮下注射REGEN-COV用于新冠病毒感染预防有效吗？, objectType=article, longId=215473, objectId=007c2154e30b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007c2154e30b, replyNumber=0, likeNumber=77, createdTime=2021-08-10, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007c2154e30b, moduleTitle=NEJM：皮下注射REGEN-COV用于新冠病毒感染预防有效吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=007c2154e30b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372256, encodeId=5a1e13e2256f9, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=罗氏曲妥珠单抗皮下注射液申报上市，给药时间仅需2-5分钟, objectType=article, longId=210360, objectId=43fb210360da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43fb210360da, replyNumber=0, likeNumber=97, createdTime=2021-04-25, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43fb210360da, moduleTitle=罗氏曲妥珠单抗皮下注射液申报上市，给药时间仅需2-5分钟, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=43fb210360da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372255, encodeId=9ec413e2255be, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, objectType=article, longId=208994, objectId=4de32089940d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4de32089940d, replyNumber=0, likeNumber=93, createdTime=2021-03-27, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4de32089940d, moduleTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4de32089940d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372254, encodeId=810713e2254dc, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Lancet Oncol：曲妥珠单抗联合帕妥珠单抗固定剂量皮下注射治疗HER2阳性乳腺癌的疗效可媲美静脉用药！, objectType=article, longId=204808, objectId=a44820480803, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44820480803, replyNumber=0, likeNumber=75, createdTime=2020-12-24, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44820480803, moduleTitle=Lancet Oncol：曲妥珠单抗联合帕妥珠单抗固定剂量皮下注射治疗HER2阳性乳腺癌的疗效可媲美静脉用药！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a44820480803)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372253, encodeId=a82a13e225363, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=全球**皮下注射PD-L1抗体KN035（恩沃利单抗注射液）美国注册临床试验完成首例患者给药, objectType=article, longId=204434, objectId=6b8c20443418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b8c20443418, replyNumber=0, likeNumber=67, createdTime=2020-12-14, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b8c20443418, moduleTitle=全球**皮下注射PD-L1抗体KN035（恩沃利单抗注射液）美国注册临床试验完成首例患者给药, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6b8c20443418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372252, encodeId=20a213e22528e, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=皮下注射PD-L1在中国申报上市，拟优先审评, objectType=article, longId=200936, objectId=f3b920093688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3b920093688, replyNumber=0, likeNumber=82, createdTime=2020-09-21, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3b920093688, moduleTitle=皮下注射PD-L1在中国申报上市，拟优先审评, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f3b920093688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372251, encodeId=c09213e2251a1, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, objectType=article, longId=200589, objectId=14462005895e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14462005895e, replyNumber=0, likeNumber=68, createdTime=2020-09-13, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14462005895e, moduleTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=14462005895e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372250, encodeId=381513e2250ff, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=NEJM：皮下注射Nemolizumab治疗特应性皮炎瘙痒, objectType=article, longId=197293, objectId=abf119e29367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf119e29367, replyNumber=0, likeNumber=73, createdTime=2020-07-11, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf119e29367, moduleTitle=NEJM：皮下注射Nemolizumab治疗特应性皮炎瘙痒, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=abf119e29367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372249, encodeId=622213e22497b, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点, objectType=article, longId=196488, objectId=a16319648829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a16319648829, replyNumber=0, likeNumber=75, createdTime=2020-06-27, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a16319648829, moduleTitle=每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a16319648829)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

皮下注射

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#皮下注射# #埃万妥单抗# #拉泽替尼#

四代药埃万妥单抗可皮下注射，给药时间缩短60倍且不良反应小！

2024-06-22发表于威斯康星

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

JAMA子刊：皮下注射门冬胰岛素治疗儿童轻度糖尿病酮症酸中毒的成本-效果评估

2022-09-09

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Dermatol Ther：与口服甲氨蝶呤相比，皮下注射甲氨蝶呤治疗银屑病的效果似乎更加

2022-09-03

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Neurology：静脉注射（DIZ101）、皮下注射（DIZ102）和肠内注射（LCIG）的左旋多巴的药代动力学帕金森氏症

2022-08-02

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

EHJ重磅：siRNA皮下注射有望长效降脂，长命百岁将不再是梦！

2022-03-19

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

JAAD：甲氨蝶呤从口服改为皮下注射的不良反应研究

2022-01-16

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Nat Med：2型糖尿病患者皮下注射艾塞那肽与心血管结局

2021-12-09

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

J Urol：性腺机能减退患者中，肌内注射丙酸睾酮与皮下注射庚酸睾酮哪个效果好？

2021-11-12

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

皮下注射抽到回血，药水被染红，推还是不推呢？

2021-09-24

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Mov Disord ：皮下注射左旋多巴新药，治疗帕金森，效果如何

2021-09-23

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

J Clin Oncol：伊沙佐米+皮下注射利妥昔单抗+地塞米松可有效治疗复发或难治性巨球蛋白血症！

2021-08-17

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

NEJM：皮下注射REGEN-COV用于新冠病毒感染预防有效吗？

2021-08-10

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

罗氏曲妥珠单抗皮下注射液申报上市，给药时间仅需2-5分钟

2021-04-25

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效

2021-03-27

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Lancet Oncol：曲妥珠单抗联合帕妥珠单抗固定剂量皮下注射治疗HER2阳性乳腺癌的疗效可媲美静脉用药！

2020-12-24

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

全球**皮下注射PD-L1抗体KN035（恩沃利单抗注射液）美国注册临床试验完成首例患者给药

2020-12-14

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

皮下注射PD-L1在中国申报上市，拟优先审评

2020-09-21

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性

2020-09-13

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

NEJM：皮下注射Nemolizumab治疗特应性皮炎瘙痒

2020-07-11

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点

2020-06-27

科室
- - 订阅+
  - 更多科室
工具
服务